Ishares Pharmaceuticals Etf Alpha and Beta Analysis
| IHE Etf | USD 70.20 0.76 1.09% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as iShares Pharmaceuticals ETF. It also helps investors analyze the systematic and unsystematic risks associated with investing in IShares Pharmaceuticals over a specified time horizon. Remember, high IShares Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IShares Pharmaceuticals' market risk premium analysis include:
Beta 0.0082 | Alpha (0.0004) | Risk 0.97 | Sharpe Ratio 0.0559 | Expected Return 0.0539 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
IShares |
IShares Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IShares Pharmaceuticals market risk premium is the additional return an investor will receive from holding IShares Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IShares Pharmaceuticals' performance over market.| α | -0.0004 | β | 0.01 |
IShares Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of IShares Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how IShares Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.IShares Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how IShares Pharmaceuticals etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Pharmaceuticals shares will generate the highest return on investment. By understating and applying IShares Pharmaceuticals etf market price indicators, traders can identify IShares Pharmaceuticals position entry and exit signals to maximize returns.
IShares Pharmaceuticals Return and Market Media
The median price of IShares Pharmaceuticals for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 is 67.84 with a coefficient of variation of 2.17. The daily time series for the period is distributed with a sample standard deviation of 1.47, arithmetic mean of 67.68, and mean deviation of 1.29. The Etf received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | iShares U.S. Pharmaceuticals ETF Shares Purchased by Patten Patten Inc. TN | 11/11/2024 |
2 | Long Term Investment Analysis - Stock Traders Daily | 12/04/2024 |
3 | Tuesdays big stock stories Whats likely to move the market in the next trading session | 01/14/2025 |
About IShares Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IShares or other etfs. Alpha measures the amount that position in iShares Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IShares Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IShares Pharmaceuticals' short interest history, or implied volatility extrapolated from IShares Pharmaceuticals options trading.
Build Portfolio with IShares Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out IShares Pharmaceuticals Backtesting, Portfolio Optimization, IShares Pharmaceuticals Correlation, IShares Pharmaceuticals Hype Analysis, IShares Pharmaceuticals Volatility, IShares Pharmaceuticals History and analyze IShares Pharmaceuticals Performance. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
IShares Pharmaceuticals technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.